TRPA1 and migraine disorder: It is proposed by Pierangelo Geppetti that TRPA1 is activated by pain-inducing exogenous and endogenous drugs that release pro-migraine peptides and calcitonin gene-related peptides through this neuronal pathway, which mediated the onset of headache (Benemei et al., 2014).